A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

A new trial is to take place at 10 UK locations involving patients diagnosed with multiple sclerosis (MS). It is set to investigate whether a vaccine designed to protect against a common virus found ...

Selma Blair has faced challenges that would break most people but she never gave in. From the height of Hollywood fame to her ...

Maybe healing after an MS relapse isn't in striving to feel better, but is found in savoring where you are now, writes ...

Long sustained-attention tasks more accurately identify fatigue in multiple sclerosis than short cognitive tests, suggesting the need for more sensitive clinical assessment tools.

Selma Blair exclusively told PEOPLE that she feels like she’s getting her stamina back amid her journey with multiple ...

Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

TG Therapeutics remains attractive for investors despite competition and slowing growth. Read the latest analysis on the ...

MS and MOGAD share similar symptoms but are two biologically distinct conditions, with different immune signatures, a study found ...

Diet and wellness impact multiple sclerosis management, enhancing quality of life and reducing fatigue through lifestyle ...

Multiple Sclerosis (MS) affects women far more often than men, with the current sex ratio sitting at approximately 3:1. We ...

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and ...